EGFR and hepatocellular carcinoma: Recent studies have untangled that LPS can activate (EGFR) Epidermal Growth Factor Receptor signaling in (HSCs) Hepatic Stellate Cells, leading to the release of IL-8 from tumor cells and inducing angiogenesis, thereby accelerating the invasion and metastasis of HCC[34].